ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for default 무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.

GOVXW GeoVax Labs Inc

0.035
0.00 (0.00%)
14 5월(5) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
GeoVax Labs Inc GOVXW 나스닥 주식 인수형 워런트
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
0.00 0.00% 0.035 09:00:00
개장가 저가 고가 종가 전일 종가
0.035 0.035
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
05/04/202401:30GLOBEGeoVax Presents Data on GEO-CM04S1, a Next Generation..
28/03/202422:00GLOBEGeoVax to Present Data on GEO-CM04S1, a Next Generation..
12/03/202422:00GLOBEGeoVax to Present at the 36th Annual Roth Conference
06/03/202423:00GLOBEGeoVax Achieves Milestone in Transition to Commercially..
01/03/202406:00GLOBEGeoVax Reports 2023 Year-End Financial Results and Provides..
22/02/202423:00GLOBEGeoVax to Report 2023 Financial Results and Provide..
19/02/202423:00GLOBEGeoVax to Present at the 2024 BIO CEO & Investor Conference
13/02/202423:00GLOBEGeoVax Announces Multiple Patent Issuances and Allowances
06/02/202423:00GLOBEGeoVax Reports Positive Interim Data From Phase 2 Clinical..
29/01/202423:00GLOBEGeoVax Announces 1-for-15 Reverse Stock Split to Regain..
08/01/202423:00GLOBEGeoVax Appoints Dr. Marc Pipas as Executive Medical..
04/01/202423:00GLOBEGeoVax Announces Gedeptin® Patient Enrollment Closure for..
03/01/202423:00GLOBEGeoVax Announces Issuance of Malaria Vaccine Patent
27/12/202323:00GLOBEGeoVax to Present at Biotech Showcase During J.P. Morgan..
19/12/202323:00GLOBEGeoVax Expands Rights Under NIH COVID-19 License to Include..
01/12/202306:30GLOBEGeoVax Hemorrhagic Fever Vaccine Data Presented at World..
29/11/202323:00GLOBEGeoVax to Participate in Upcoming December Investor Events
28/11/202323:00GLOBEGeoVax COVID-19 Vaccine Clinical Data Presented at World..
14/11/202323:00GLOBEProgress on GeoVax’s Universal Coronavirus Vaccine..
09/11/202306:00GLOBEGeoVax Reports Third Quarter 2023 Financial Results and..
31/10/202322:00GLOBEGeoVax to Report Third Quarter 2023 Financial Results and..
30/10/202322:00GLOBEGeoVax Commences Site Expansion for Phase 2 Trial of..
25/10/202322:00GLOBEGeoVax to Participate in Upcoming November Investor and..
24/10/202322:00GLOBEGeoVax Update: Clinical and Operational Progress Toward..
09/10/202322:00GLOBEGeoVax Receives Notice of Allowance for Marburg Vaccine..
05/10/202322:00GLOBEGeoVax Receives Notice of Allowance for HIV Vaccine Patent
27/09/202322:00GLOBEGeoVax to Participate in Upcoming October Investor and..
26/09/202322:00GLOBEGeoVax Secures Multi-Product License for ProBioGen's..
20/09/202322:00GLOBEGeoVax Next-Generation COVID-19 Vaccine Data Presented at..
19/09/202322:00GLOBEGeoVax Next-Generation COVID-19 Vaccine Demonstrates Potent..
12/09/202322:00GLOBEGeoVax Presents Corporate Update at the H.C. Wainwright 25th..
11/09/202322:00GLOBEGeoVax Completes Enrollment of Phase 2 Trial for..
31/08/202322:00GLOBEGeoVax to Present at the H.C. Wainwright 25th Annual Global..
28/08/202322:00GLOBEGeoVax Receives Notice of Allowance for Malaria Vaccine..
10/08/202322:00GLOBEGeoVax Announces First Patients Vaccinated in Phase 2..
10/08/202305:00GLOBEGeoVax Reports 2023 Second Quarter Financial Results and..
26/07/202322:00GLOBEGeoVax to Report Second Quarter 2023 Financial Results and..
24/07/202322:00GLOBEGeoVax Announces Issuance of Ebola Vaccine Patent
20/07/202322:00GLOBEGeoVax Announces Initiation of Phase 2 Clinical Trial of..
10/07/202322:00GLOBEGeoVax Presents Gedeptin® Clinical Data at the AACR-AHNS..
28/06/202322:00GLOBEGeoVax Announces Gedeptin® Presentation at the AACR-AHNS..
27/06/202323:15GLOBEGeoVax Universal Coronavirus Vaccine Design & Development..
31/05/202322:00GLOBEGeoVax Partners With ABL to Advance cGMP Production of..
25/05/202322:00GLOBEGeoVax to Participate in Upcoming Industry Meetings
24/05/202321:00GLOBEGeoVax’s Next-Generation COVID-19 Vaccine Shows High..
15/05/202322:00GLOBEGeoVax Next-Generation COVID-19 Vaccine Data to be Presented..